Loading...

HUTCHMED (China) Limited

0013.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$21.00
HK$-0.26(-1.22%)
Hong Kong Market opens in 29h 51m

HUTCHMED (China) Limited (0013.HK) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap18.1B
P/E Ratio5.09
EPS (TTM)$4.15
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$22.97
3 Months$23.56
1 Year Target$22.82

0013.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (0013.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.09 and a market capitalization of 18.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.22%
5-Day Change
-0.66%
1-Month Change
-9.72%
3-Month Change
-10.18%
6-Month Change
-11.09%
Year-to-Date (YTD) Change
1.84%
1-Year Change
-7.28%
3-Year Change
-14.81%
5-Year Change
-65.17%
All-Time (Max) Change
-65.17%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

1,811 Employees
IPO DateJun 30, 2021
CountryHK
Actively Trading

Frequently Asked Questions